Mouthwash may prevent agonizing side effect of stem cell transplants
NCT ID NCT07325383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special mouthwash containing N-acetylcysteine can prevent painful mouth sores (oral mucositis) in patients receiving a stem cell transplant. These sores are a common and serious side effect that can cause severe pain and longer hospital stays. The trial involves 106 adult patients and compares the mouthwash to a placebo to see if it safely reduces the number of people who develop these sores.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Institute of Oncology, Hematology, and Cell Therapy, Shariati Hospital
Tehran, Iran
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo make stem cell transplants safer for frail AML patients?
- Can a needle at the wrist calm Chemotherapy's queasiness?
- Olive oil and xylitol mouth rinse may shield cancer patients from painful mouth sores
- Can laser or ozone therapy better soothe cancer-related mouth pain? a head-to-head comparison
- Blood test clues could make antifungal dosing safer for transplant patients
- Plant pigment could soothe Radiation's harsh side effect in blood cancer treatment